Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Oral Thin Film Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.
This report presents the market size and development trends by detailing the Oral Thin Film Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oral Thin Film Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oral Thin Film Drug industry and will help you to build a panoramic view of the industrial development.
Oral Thin Film Drug Market, By Type:
Sublingual films
Fast dissolving dental/buccal films
Oral Thin Film Drug Market, By Application:
Schizophrenia
Opioid dependence
Migraine, nausea & vomiting
Other Applications
Some of the leading players are as follows:
Indivior plc
Allergan plc
IntelGenx Corp.
Novartis AG
Sumitomo Dainippon Pharma Co
Aquestive Therapeutics, Inc
Pfizer, Inc
NAL Pharma.
ZIM Laboratories Limited.
Solvay.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Oral Thin Film Drug Market: Technology Type Analysis
-
4.1 Oral Thin Film Drug Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Oral Thin Film Drug Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Sublingual films
4.3.2 Fast dissolving dental/buccal films
5 Oral Thin Film Drug Market: Product Analysis
-
5.1 Oral Thin Film Drug Product Market Share Analysis, 2018 & 2026
-
5.2 Oral Thin Film Drug Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Oral Thin Film Drug Market: Application Analysis
-
6.1 Oral Thin Film Drug Application Market Share Analysis, 2018 & 2026
-
6.2 Oral Thin Film Drug Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Schizophrenia
6.3.2 Opioid dependence
6.3.3 Migraine, nausea & vomiting
6.3.4 Other Applications
7 Oral Thin Film Drug Market: Regional Analysis
-
7.1 Oral Thin Film Drug Regional Market Share Analysis, 2018 & 2026
-
7.2 Oral Thin Film Drug Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Indivior plc
9.1.1 Indivior plc Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Allergan plc
9.2.1 Allergan plc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 IntelGenx Corp.
9.3.1 IntelGenx Corp. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Novartis AG
9.4.1 Novartis AG Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sumitomo Dainippon Pharma Co
9.5.1 Sumitomo Dainippon Pharma Co Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Aquestive Therapeutics, Inc
9.6.1 Aquestive Therapeutics, Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Pfizer, Inc
9.7.1 Pfizer, Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 NAL Pharma.
9.8.1 NAL Pharma. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 ZIM Laboratories Limited.
9.9.1 ZIM Laboratories Limited. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Solvay.
9.10.1 Solvay. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 74 Figures and 122 Tables)
Figure Sublingual films Oral Thin Film Drug market, 2015 - 2026 (USD Million)
Figure Fast dissolving dental/buccal films Oral Thin Film Drug market, 2015 - 2026 (USD Million)
Figure Schizophrenia market, 2015 - 2026 (USD Million)
Figure Opioid dependence market, 2015 - 2026 (USD Million)
Figure Migraine, nausea & vomiting market, 2015 - 2026 (USD Million)
Figure Other Applications market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Oral Thin Film Drug market, by country, 2015 - 2026 (USD Million)
-
Table North America Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table North America Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table North America Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Canada Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Canada Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Europe Oral Thin Film Drug market, by country, 2015 - 2026 (USD Million)
-
Table Europe Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Europe Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Europe Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Germany Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Germany Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table France Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table France Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Italy Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Italy Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Spain Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Spain Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Thin Film Drug market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table China Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table China Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Japan Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Japan Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table India Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table India Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Oral Thin Film Drug market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table MEA Oral Thin Film Drug market, by country, 2015 - 2026 (USD Million)
-
Table MEA Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table MEA Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table MEA Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Oral Thin Film Drug market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Thin Film Drug market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Thin Film Drug market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Indivior plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IntelGenx Corp. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sumitomo Dainippon Pharma Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aquestive Therapeutics, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NAL Pharma. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ZIM Laboratories Limited. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Solvay. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
